| Bioactivity | CGS 20625 is a potent, selective and orally active partial agonist for the central benzodiazepine receptor. CGS 20625 inhibits [3H]-flunitrazepam binding to central benzodiazepine receptors with an IC50 of 1.3 nM. CGS 20625 can be used for the research of pentylenetetrazol-induced seizures[1]. |
| Target | IC50: 1.3 nM (-flunitrazepam binding to central benzodiazepine receptors) |
| Name | CGS 20625 |
| CAS | 111205-55-1 |
| Formula | C18H19N3O2 |
| Molar Mass | 309.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Williams M, et al. CGS 20625, a novel pyrazolopyridine anxiolytic. J Pharmacol Exp Ther. 1989 Jan;248(1):89-96. |
CGS 20625
CAS: 111205-55-1 F: C18H19N3O2 W: 309.36
CGS 20625 is a potent, selective and orally active partial agonist for the central benzodiazepine receptor. CGS 20625 in
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.